Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)-Reference-Cited by-同舟云学术

Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

Published:2014-06-15 Issue:2 Volume:74 Page:333-340
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Katopodis O.,Souglakos J.,Stathopoulos E.,Christopoulou A.,Kontopodis E.,Kotsakis A.,Kalbakis K.,Kentepozidis N.,Polyzos A.,Hatzidaki D.,Georgoulias V.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-014-2509-6.pdf

Reference27 articles.

1. Brodoefel H, Bethge W, Vogel M et al (2010) Early and late-onset acute GvHD following hematopoietic cell transplantation: CT features of gastrointestinal involvement with clinical and pathological correlation. Eur J Radiol 73:594–600

2. Malvezzi M, Bertuccio P, Levi F et al (2014) European cancer mortality predictions for the year 2014. Ann Oncol. doi: 10.1093/annonc/mdu138

3. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150

4. Goulart BH, Clark JW, Lauwers GY et al (2009) Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis. J Hematol Oncol 2:13

5. Burris HA III, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long Term Outcomes of No-Touch Isolation Principles Applied in Pancreaticoduodenectomy for Treatment of Pancreatic Adenocarcinoma: A Multicenter Retrospective Study with Propensity Score Matching;Journal of Clinical Medicine;2023-01-12

2. Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities;World Journal of Gastroenterology;2021-10-21

3. Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation;Journal of Pharmacology and Experimental Therapeutics;2021-03-22

4. Critical steps to tumor metastasis: alterations of tumor microenvironment and extracellular matrix in the formation of pre-metastatic and metastatic niche;Cell & Bioscience;2020-07-28

5. Exosomal miRNA‐1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer;Cancer Medicine;2019-10-23